Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pilot Study converted to NCT 05660512 prospective single arm cohort study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| M Squared Associates, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The Intracept Global Registry is a prospective, noninterventional, observational global post market independent data collection of the ongoing effectiveness, safety, and satisfaction outcomes for patients treated with the Intracept Procedure. This registry will be conducted according to Good Clinical Practice (GCP) guidelines, including participant verbal informed consent and Independent Review Board (IRB) / Ethics Committee (EC) approval and oversight.
Registry design, conduct, analysis, and reporting are overseen by the Principal Investigator (PI) and the cross-specialty TIGR Physician Steering Committee.
Participants in the registry will have seven study visits over a period of five years (one prior to procedure and 6 post their procedure). Study visits will be conducted via telephone by a third-party CRO and independent clinical research coordinators. Participants will be verbally consented and then evaluated via telephonic study visits at baseline (prior to procedure) and at 3, 12, 24, 36, 48, and 60 months post their Intracept Procedure.
Primary and secondary objectives are based on patient reported outcomes for functional improvement, pain reduction, and physical and mental health pre and post procedure. The study will also look at utilization of injections and pain interventions/surgery for treatment of low back pain post Intracept.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intracept Procedure | Procedure | radio frequency ablation of the basivertebral nerve for the relief of chronic vertebrogenic low back pain |
| Measure | Description | Time Frame |
|---|---|---|
| Oswestry Disability Index (ODI) Reduction | Validated questionnaire of low back pain related disability. Comprised of 10 questions evaluating the impact of low back pain on activities of daily living. The ODI is scored on a scale of 0 (no disability) to 100 (complete disability), with categories of 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). Comparison of mean ODI baseline to 3 months. | 3 months post procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Oswestry Disability Index (ODI) improvement | Mean improvement in ODI scores from baseline (scale 0 to 100) | 3, 12, 24, 36, 48 and 60 months post procedure |
| Numeric Pain Score | Mean reduction in patient reported low back pain from baseline (scale 0 no pain to 10 worst pain imaginable) |
Not provided
Inclusion Criteria:
All patients scheduled for the Intracept procedure and whose treating physician is referring to the registry
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients that have the Intracept procedure and whose treating physician is referring to the registry
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zachary McCormick, MD, FAAPMR | Spine and Pain Medicine, University of Utah School of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Utah | Salt Lake City | Utah | 84112 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40891888 | Derived | McCormick ZL, Fogarty AE, Conger A, Burnham T, Kendall R, Dickenson BA, Kanjanapanang N, Curtis TM, Sen H, Glinka Przybysz A, Clark T, Smolinski K, Wagner G, Teramoto M, Cooper AN. The effectiveness of basivertebral nerve radiofrequency ablation for the treatment of vertebrogenic low back pain: 1-year results of a prospective real-world cohort study. Pain Med. 2026 Mar 1;27(3):254-261. doi: 10.1093/pm/pnaf122. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017116 | Low Back Pain |
| ID | Term |
|---|---|
| D001416 | Back Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3, 12, 24, 36, 48 and 60 months post procedure |
| Combined Responder Rates (improvement thresholds of ODI ≥ 15 and NPS ≥ 2) | Percent of responders meeting both thresholds | 3, 12, 24, 36, 48 and 60 months post procedure |
| PROMIS 29 Change | Mean change in PROMIS-29 from baseline | 3, 12, 24, 36, 48 and 60 months post procedure |
| Injections utilization compared to baseline | Numbers of injections post procedure compared to baseline | 3, 12, 24, 36, 48 and 60 months post procedure |
| Post ablation pain interventions/surgeries | Numbers of pain interventions/surgeries post procedure compared to baseline | 3, 12, 24, 36, 48 and 60 months post procedure |
| D013568 |
| Pathological Conditions, Signs and Symptoms |